anti-cancer drug

Filamon
Healthcare News, Science and Technology
Filamon secures exclusive licence for groundbreaking anti-cancer drug
Ritchelle Drilon Feb 2, 2023

Filamon was awarded an exclusive license for a groundbreaking experimental anti-cancer drug developed by Australian university scientists. Australian clinical-stage drug development company, Filamon Limited, announced

chat_bubble0 Comment visibility1172 Views

Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector

How can we help?

Request Media Kit

MENU LINKS

EVENTS

FOLLOW US

Facebook Linkedin Instagram

WRITE FOR US

We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!

Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.

2024 All rights reserved. © Healthcare channel powered by Akolade.

Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.

2024 All rights reserved. © Healthcare channel powered by Akolade.